• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Sci Rep . PaO 2/FiO 2 and IL-6 are risk factors of mortality for intensive care COVID-19 patients

tetano

Editor, Senior Moderator
Sci Rep


. 2021 Apr 1;11(1):7334.
doi: 10.1038/s41598-021-86676-3.
PaO [SUB]2[/SUB]/FiO [SUB]2[/SUB] and IL-6 are risk factors of mortality for intensive care COVID-19 patients


Yanli Gu[SUP] 1 [/SUP], Donghui Wang[SUP] 1 [/SUP], Cen Chen[SUP] 2 [/SUP], Wanjun Lu[SUP] 3 [/SUP], Hongbing Liu[SUP] 3 [/SUP], Tangfeng Lv[SUP] 3 [/SUP], Yong Song[SUP] 4 5 [/SUP], Fang Zhang[SUP] 6 7 [/SUP]



Affiliations

Abstract

To identify the risk factors of mortality for the coronavirus disease 19 (COVID-19) patients admitted to intensive care units (ICUs) through a retrospective analysis. The demographic, clinical, laboratory, and chest imaging data of patients admitted to the ICU of Huoshenshan Hospital from February 10 to April 10, 2020 were retrospectively analyzed. Student's t-test and Chi-square test were used to compare the continuous and categorical variables, respectively. The logistic regression model was employed to ascertain the risk factors of mortality. This retrospective study involved 123 patients, including 64 dead and 59 survivors. Among them, 57 people were tested for interleukin-6 (IL-6) (20 died and 37 survived). In all included patients, the oxygenation index (PaO[SUB]2[/SUB]/FiO[SUB]2[/SUB]) was identified as an independent risk factor (odd ratio [OR] = 0.96, 95% confidence interval [CI]: 0.928-0.994, p = 0.021). The area under the curve (AUC) was 0.895 (95% CI: 0.826-0.943, p < 0.0001). Among the patients tested for IL-6, the PaO[SUB]2[/SUB]/FiO[SUB]2[/SUB] (OR = 0.955, 95%CI: 0.915-0.996, p = 0.032) and IL-6 (OR = 1.013, 95%CI: 1.001-1.025, p = 0.028) were identified as independent risk factors. The AUC was 0.9 (95% CI: 0.791-0.964, p < 0.0001) for IL-6 and 0.865 (95% CI: 0.748-0.941, p < 0.0001) for PaO[SUB]2[/SUB]/FiO[SUB]2[/SUB]. PaO[SUB]2[/SUB]/FiO[SUB]2[/SUB] and IL-6 could potentially serve as independent risk factors for predicting death in COVID-19 patients requiring intensive care.
 
Back
Top Bottom